Pharma Finance and Investment News
Mer_Studio Shutterstock
Concinnity Genetics raises £3m
Concinnity Genetics, an Edinburgh-based gene control company, has announced the closure of its oversubscribed £3m seed funding round. Read more
19 Dec 2024
Pharma Manufacturing News + Pharma Finance and Investment News
tech_BG Shutterstock
Noema Pharma extends Series B financing round
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced the close of a Series B extension financing round with an investment from EQT Life Sciences. Read more
17 Dec 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Pixel Alchemy/Adobe Stock
Starget Pharma secures $5.1 million investment for targeted cancer therapy
ARC Innovation announced the successful $5.1 million funding round of Starget Pharma, a startup specialising in precise cancer diagnosis and targeted radiotherapy. Read more
5 Nov 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Katy Balls/Getty Images
R&D funding and capital gains: What the budget means for life sciences
This week’s budget saw several major announcements for the UK life sciences sector. Yogan Patel, head of life sciences for MHA, the UK member firm of the global Baker Tilly network, explores what’s been announced and what it means for the industry. Read more
1 Nov 2024
Pharma Manufacturing News + Pharma Finance and Investment News
IM Imagery/Adobe Stock
Recipharm invests in sterile development capabilities
Recipharm is expanding its pharmaceutical development capabilities through targeted investments and the integration of advanced technologies. Read more
4 Oct 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Medix Biochemica
DevCo completes €616 million capital raise for investment in Medix Biochemica
DevCo Partners Ltd has announced a capital raise resulting in 616 MEUR of total commitments for its long-term single asset investment vehicle for Medix Biochemica. Read more
16 Sep 2024
Pharma Manufacturing News + Pharma Finance and Investment News
New Africa / Shutterstock.com
ILC Therapeutics completes £2.5m financing round and bolsters C-suite
ILC Therapeutics, a specialist developer of hybrid interferons, a new drug class engineered for improved therapeutic profiles across multiple indications, has announced that it has successfully completed a fundraise of £2.5m. Read more
11 Sep 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Lightspring / Shutterstock.com
Mestag Therapeutics awarded £1.5m Innovate UK grant to accelerate the Path to Clinic for MST-0300
Mestag Therapeutics has announced that it has been awarded a “Transforming Cancer Therapeutics” grant from Innovate UK’s Cancer Therapeutics program of £1.5 million to accelerate the development of its MST-0300 antibody. Read more
28 Aug 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Abselion
Abselion announces £1.1m project to develop next-gen cell platform for viral vector production
Biotechnology companies and research organisations in the UK and Canada are entering into a R&D project jointly funded by a 1.1 million GBP grant from Innovate UK and the National Research Council of Canada Industrial Research Assistance Program. Read more
21 Aug 2024
Pharma Manufacturing News + Pharma Finance and Investment News
GreenOak Shutterstock
How Adragos is building a more resilient pharma supply chain
The global pharmaceutical industry is facing unprecedented supply chain challenges in the current climate of geopolitical uncertainty. Marco Gorgas, chief technical officer, Adragos Pharma explains. Read more
20 Dec 2024
Pharma Manufacturing News + Pharmaceutical Logistics & Distribution News
BOY ANTHONY Shutterstock
Neuraxpharm and Pharmathen enter into strategic co-development agreement
Neuraxpharm Group (Neuraxpharm) and Pharmathen have announced a strategic alliance to co-develop new long-acting injectable therapies within the psychiatry field under Pharmathen’s long-acting therapeutic technologies (LATT) program. Read more
20 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
PeopleImages.com - Yuri A Shutterstock
NEC announces interim results from Phase 1 clinical trial
NEC Bio Therapeutics presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1. Read more
20 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Freudenberg
Freudenberg Sealing Technologies enhances safety of modern lithium-ion batteries
Freudenberg Sealing Technologies is working on enhancing the safety of modern lithium-ion batteries, thereby advancing the future of electromobility. Read more
20 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Ahmed Hamaki Shutterstock
Mary Marcus appointed CEO of NewAge Industries
NewAge Industries, parent company of AdvantaPure and NewAge Performance Products, has announced the appointment of Mary Marcus to the position of CEO. Read more
19 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Phastar
Phastar scoops 2024 Scrip Award
Phastar, a specialist biometrics contract research organisation (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards. Read more
19 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
TierneyMJ / Shutterstock.com
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
